Nosocomial septicemia in patients undergoing sclerotherapy for variceal hemorrhage.
The data of 19 consecutive unselected patients undergoing emergency sclerotherapy who were admitted to a single intensive care unit throughout the course of one year, were analyzed retrospectively for clinical and bacteriological signs of septicemia after the first sclerotherapy session. Ten had fever and/or chills, and in six of these patients microorganisms were cultured from arterial blood or central venous catheter tips. The data show that about one-third of patients with liver cirrhosis and acute variceal hemorrhage undergoing emergency sclerotherapy may develop septic disease.
D000328:Adult; D000368:Aged; D003428:Cross Infection / Q000209:etiology*; D004630:Emergencies; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D007267:Injections / Q000009:adverse effects; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000008:administration & dosage; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000008:administration & dosage; D018805:Sepsis / Q000209:etiology*
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols